Corrigendum: Mitigation of acetaminophen-induced liver toxicity by the novel phosphatidylinositol 3-kinase inhibitor alpelisib.

DAMPs acetaminophen alpelisib hepatotoxicity phosphatidylinositol 3-kinase

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2023
Historique:
received: 22 08 2023
accepted: 30 08 2023
medline: 25 9 2023
pubmed: 25 9 2023
entrez: 25 9 2023
Statut: epublish

Résumé

[This corrects the article DOI: 10.3389/fphar.2023.1212771.].

Identifiants

pubmed: 37745058
doi: 10.3389/fphar.2023.1281416
pii: 1281416
pmc: PMC10513751
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

1281416

Commentaires et corrections

Type : ErratumFor

Informations de copyright

Copyright © 2023 Shaker, Gomaa, Hazem, Abdelgawad, El-Mesery and Shaaban.

Auteurs

Mohamed E Shaker (ME)

Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka, Al-Jouf, Saudi Arabia.

Hesham A M Gomaa (HAM)

Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka, Al-Jouf, Saudi Arabia.

Sara H Hazem (SH)

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.

Mohamed A Abdelgawad (MA)

Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka, Al-Jawf, Saudi Arabia.

Mohamed El-Mesery (M)

Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
Division of Biochemical Pharmacology, Department of Biology, University of Konstanz, Konstanz, Germany.

Ahmed A Shaaban (AA)

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
Department of Pharmacology and Biochemistry, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt.

Classifications MeSH